Ukraine provides access to chemotherapy, targeted drugs, and immunotherapy through specialized oncology centers. While standard chemotherapy is widely accessible, targeted therapies and immunotherapies are primarily available via private networks like Spizhenko Clinic or international clinical trials. War-related logistics currently impact supply consistency.
- Systemic chemotherapy: Public oncology centers provide standard regimens like FOLFOX for colon cancer.
- Targeted therapy accessibility: Drugs like Bevacizumab are available mainly through private clinics or imports.
- Immunotherapy availability: Advanced treatments like Pembrolizumab are accessible at private centers like Spizhenko.
- Technological standards: Private institutions follow NCCN international protocols for stage-specific cancer care.
Bookimed Expert Insight: Kyiv remains the primary hub for advanced systemic therapies in Ukraine. Dievo Surgery Center and Spizhenko Clinic manage high patient volumes, serving over 70,000 international patients combined. Data shows private networks maintain more stable supply chains for imported drugs than public facilities. For colon cancer, patients often combine local surgery with systemic drugs sourced through these established private channels.
Patient Consensus: Patients note that while surgery and basic chemo are reliable, securing specific targeted drugs often requires private funding. Many suggest verifying current stock at the National Cancer Institute in Kyiv before starting treatment cycles.
